Navigation Links
Transforming medical diagnosis with new scanning technology
Date:3/26/2009

A new technology which dramatically improves the sensitivity of Magnetic Resonance techniques including those used in hospital scanners and chemistry laboratories has been developed by scientists at the University of York.

Ultimately, the technique, based on manipulating parahydrogen, the fuel of the space shuttle, is expected to allow doctors to learn far more about a patient's condition from an MRI scan at lower cost while increasing the range of medical conditions that can be examined.

The research is published in the latest edition of the journal Science.

Researchers have taken parahydrogen and, through a reversible interaction with a specially designed molecular scaffold, transferred its magnetism to a range of molecules. The resulting molecules are much more easily detected than was previously possible. No-one has been able to use parahydrogen in this way before.

Professor Gary Green, from the Department of Psychology and Director of the York Neuroimaging Centre, said: "Our method has the potential to help doctors make faster and more accurate diagnoses in a wide range of medical conditions.

"The technique could ultimately replace current clinical imaging technologies that depend on the use of radioactive substances or heavy metals, which themselves create health concerns."

The new method will also have major implications for scientific research because it radically reduces the time taken to obtain results using Nuclear Magnetic Resonance technology, the most popular method for obtaining analytical and structural information in chemistry.

Professor Simon Duckett, from the University's Department of Chemistry and Director of the Centre for Magnetic Resonance, said: "We have been able to increase sensitivity in NMR by over 1000 times so data that once took 90 days to record can now be obtained in just five seconds. Similarly, an MRI image can now be collected in a fraction of a second rather than over 100 hours.

"This development opens up the possibility of using NMR techniques to better understand the fundamental functions of biological systems."

Professor Ian Greer, Dean of the Hull York Medical School, said: "This technological advance has the potential to revolutionise the accessibility and application of high quality medical imaging to patients. It will bring significant to benefits to diagnosis and treatment in virtually all areas of medicine and surgery, ranging from cancer diagnosis to orthopaedics and trauma. It illustrates the enormous success of combining high quality basic science with clinical application."

Bruker BioSpin has been one of the first collaborators in developing this technology for commercial use. Dr Tonio Gianotti, Director and International NMR Research and Development Co-ordinator for Bruker BioSpin, said: "This technology has the potential to revolutionise both NMR and MRI methods in a short space of time."

Dr Mark Mortimer, Director of the University's Research and Enterprise Office, said: "The rapid development of this research from the chemistry bench through to measurement opens up many exciting possibilities to extend this work. The York research team are now seeking partners to help turn this groundbreaking research into commercial and medical applications."


'/>"/>

Contact: James Reed
jr576@york.ac.uk
44-190-443-2029
University of York
Source:Eurekalert

Related biology technology :

1. Excalibur - Transforming Biotech Deals can Still be Achieved
2. SkyeTek to Present Webinar on Transforming the Management of Medical Devices & Supplies with Embedded RFID
3. US Patent Office Rejects 95% of Verathon Claims in Patent Case With Aircraft Medical
4. Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy
5. Encision Enters Into Sales Representation Agreement With Caldera Medical
6. Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates
7. Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences
8. The NIHR Biomedical Research Centre for Mental Health London has Joined the MetaMiner CNS Partnership Program
9. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
10. ArunA Biomedical, Inc. Announces Alliance with Neuromics for Distribution of Normal Human Neural Cells
11. Occlutech Obtains Favourable Ruling in Proceedings Initiated by AGA Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... January 20, 2017 Stock-Callers.com explores ... have influenced the most recent performances of select equities. ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... Grand View Research, global Biotech market size is expected to reach $604.40 ...
(Date:1/20/2017)... January 20, 2017 http://www.Financialbuzz.com ... one of leading causes of death worldwide. There were ... number of cancer related deaths increased gradually over time, ... incidence rate of various cancers continues to drive demand ... report by Global Market Insights, Inc. cancer biological therapy ...
(Date:1/19/2017)... 19, 2017 Research and Markets has announced ... Biomolecules, Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, ... ... global market is projected to reach $15,737 million by 2022 from ... to 2022. Omic technologies segment accounted for more ...
(Date:1/19/2017)... and HOUSTON , ... ("NX Prenatal") today announced the formation of its ... leading clinicians and industry veterans who enhance the ... as it accelerates development of its novel prenatal ... provide medical, clinical and strategic guidance for the ...
Breaking Biology Technology:
(Date:1/6/2017)... NEWARK, Calif. , Jan. 5, 2017  Delta ... introduced its iris scanning technology for automotive at CES® ... GNTX ) to demonstrate the use of ... to identify and authenticate the driver in a car, ... automobiles during the driving experience. Delta ID ...
(Date:12/22/2016)... 2016  As part of its longstanding mission to improve ... company, recently released its latest children,s book, titled ... on the topics of inheritance and variation of traits that ... in elementary school classrooms in the US. ... Ariana Killoran , whose previous book with 23andMe, ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016 /PRNewswire/ ... que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que ... de tumor en 2017, con múltiples sitios previstos a lo largo ... ... en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que ...
Breaking Biology News(10 mins):